Bausch Health
BHC
#5271
Rank
โ‚น160.48 B
Marketcap
โ‚น429.71
Share price
-2.41%
Change (1 day)
-25.24%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -โ‚น307.11

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -โ‚น312.86. In 2025 the company made an earnings per share (EPS) of โ‚น40.56 an increase over its 2024 EPS that were of -โ‚น11.59.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น307.11-857.24%
2025โ‚น40.56-450%
2024-โ‚น11.59-92.59%
2023-โ‚น156.43160.89%
2022-โ‚น59.96-76.64%
2021-โ‚น256.6668.45%
2020-โ‚น152.37-68.91%
2019-โ‚น490.05-57.11%
2018-โ‚น1,143-272.22%
2017โ‚น663.50-199.29%
2016-โ‚น668.22798.7%
2015-โ‚น74.35-128.31%
2014โ‚น262.65-204.62%
2013-โ‚น251.06602.7%
2012-โ‚น35.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-โ‚น26.07-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น91.73-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA